- Home
- MMD vs ARAY Comparison
MMD vs ARAY Comparison
Compare MMD & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMD
- ARAY
- Stock Information
- Founded
- MMD 2012
- ARAY 1990
- Country
- MMD United States
- ARAY United States
- Employees
- MMD N/A
- ARAY N/A
- Industry
- MMD Investment Managers
- ARAY Medical/Dental Instruments
- Sector
- MMD Finance
- ARAY Health Care
- Exchange
- MMD Nasdaq
- ARAY Nasdaq
- Market Cap
- MMD 274.9M
- ARAY 229.3M
- IPO Year
- MMD N/A
- ARAY 2007
- Fundamental
- Price
- MMD $14.55
- ARAY $1.59
- Analyst Decision
- MMD
- ARAY Strong Buy
- Analyst Count
- MMD 0
- ARAY 1
- Target Price
- MMD N/A
- ARAY $5.00
- AVG Volume (30 Days)
- MMD 74.7K
- ARAY 840.7K
- Earning Date
- MMD 01-01-0001
- ARAY 08-13-2025
- Dividend Yield
- MMD 4.88%
- ARAY N/A
- EPS Growth
- MMD N/A
- ARAY N/A
- EPS
- MMD N/A
- ARAY N/A
- Revenue
- MMD N/A
- ARAY $458,505,000.00
- Revenue This Year
- MMD N/A
- ARAY $1.25
- Revenue Next Year
- MMD N/A
- ARAY N/A
- P/E Ratio
- MMD N/A
- ARAY N/A
- Revenue Growth
- MMD N/A
- ARAY 2.68
- 52 Week Low
- MMD $14.30
- ARAY $1.14
- 52 Week High
- MMD $17.67
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- MMD 44.12
- ARAY 62.94
- Support Level
- MMD $14.40
- ARAY $1.48
- Resistance Level
- MMD $14.62
- ARAY $1.64
- Average True Range (ATR)
- MMD 0.26
- ARAY 0.09
- MACD
- MMD -0.02
- ARAY 0.02
- Stochastic Oscillator
- MMD 12.50
- ARAY 86.49
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.